Engineered virus platform
Herpes simplex virus
Herpes simplex virus type 1 offers a large genome and a well-characterized replication cycle, which makes it suitable for oncolytic and gene delivery studies where a substantial payload capacity is required.
-
Large payload capacity
The HSV-1 genome accommodates multiple or large transgenes without loss of viability.
-
Immunomodulatory payloads
GM-CSF-armed HSV-1 constructs for immune activation studies.
-
Fluorescent variants
mCherry-labeled HSV-1 for tracking infection and spread in culture.
-
Propagation and release
Amplification with titer determination and contamination testing.
Typical applications
- Oncolytic HSV-1 mechanism of action studies
- Immune activation and payload comparison
- Neuronal gene delivery research
- Viral spread tracking with fluorescent reporters
Specifications
- Catalog constructs
- Armed and reporter HSV-1 variants
- Volume
- 1 mL
- Promoter
- Endogenous HSV-1 promoter
- Custom engineering
- Payload design and deletion strategy on request
Others in Oncolytic Virus
-
Oncolytic adenovirus
Oncolytic adenoviruses are the most widely used oncolytic platform. FuBio supplies adenoviral constructs with...
-
Newcastle disease virus
Newcastle disease virus replicates preferentially in tumor cells and has a strong record as an oncolytic and...
-
Vesicular stomatitis virus
Vesicular stomatitis virus is a fast-replicating, cytoplasmically replicating vector widely used to study...
Need a specification or a quotation?
Send the vector, payload and scale you need. We reply with feasibility, lead time and price within one business day.